India to Kenya: Clonazepam Export Trade Route

The India to Kenya Clonazepam corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $56.7K USD. The route is dominated by CENTURION HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's clonazepam manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $7.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with clonazepam's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 15.2%, placing it at rank #10 among India's top clonazepam export destinations globally.

On the import side, key buyers of Indian clonazepam in Kenya include TO THE ORDER OF, M S GENERICS AFRICA LIMITED, KRISHNA CHEMISTS LTD and 1 others. TO THE ORDER OF is the single largest importer with 3 shipments valued at $28.4K USD.

India's clonazepam exports to Kenya are driven primarily by a handful of large-scale manufacturers. CENTURION HEALTHCARE PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CENTURION HEALTHCARE PRIVATE LIMITED, VERVE HUMAN CARE LABORATORIES, VENOR PHARMA LIMITED — together account for 98% of total trade value on this route. The average shipment value of $7.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceuticals:brand. clopam tab. clonazepam bp 2mg.b.no.ep792302ep792303. md.apr.2023 ed.mar.2026 and pharmaceuticals:brand. clopam tab.clonazepam bp 2 mg.b.no.ep792401 md.jan.2024ed.dec.2026, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 3 shipments worth $28.4K USD — representing 50% of all clonazepam imports from India on this route.